Metabolomics (MRG)

Metabolomics Research Group 2022 Study

- Compound Identification –

Consistent and accurate compound identification is a major challenge for LC/MS based metabolomics. The presence of multiple isomeric compounds, matrix effects, low and varying analyte concentration, and in source fragmentation and adduct formation are major contributing factors to this challenge. A combination of accurate mass MS1, MS2 fragmentation, and retention time (RT) of external standards is frequently used to provide a high confidence, though unconfirmed, compound identification. However, given this information (MS1, MS2, RT) it is unclear how much compound identification success will vary from lab to lab. The aim of this study is to quantify inter-personal and inter-lab variability of compound identification.

The target population of this study are PIs, trainees, and professional staff of metabolomics laboratories. More than one participant from each lab can participate so we can assess not only inter- but also intra-lab variability of compound identification accuracy.

The study participants are provided with two datasets. They have the option to return results for only one dataset or both datasets.

The study material can be downloaded as a single Zip file: https://osf.io/xbgc5/download. It consists of an Excel spreadsheet including instructions and a survey (MRG_CompoundID study.xlsx) and two mzML data files (MS1.mzML and ddMS2.mzML). The Excel file is used for returning results by email.

IMPORTANT: All results are submitted anonymously, identified only by an 8-digit identification number that you select.

Please return your results to mrgabrf2022@gmail.com no later than December 31, 2022.

If you have any questions please contact Ryan Sheldon or Chris Turck.

Mission

The aims of the Metabolomics Research Group are a) to educate research scientists and resource facilities in the analytical approaches and management of data resulting from comprehensive metabolite studies and b) to promote the science and standardization of metabolomic analyses for a variety of applications. Group efforts will also include conducting surveys and organizing sessions at the annual ABRF meeting to explore the current state of the art in the field and the organization of research studies.

Questions or interest in joining an ABRF research group?

Metabolomics is the comprehensive profiling of metabolites and other small molecules. The large structural diversity of these compounds makes both comprehensive profiling and identification challenging. The major platforms are NMR and mass spectrometry, particularly LC/MS and GC/MS. There is currently a great variety of approaches, including untargeted profiling, targeted approaches, and fluxomics. Both semi-quantitative and quantitative approaches can be used. Challenges include identification of metabolites and how they change in relation to a biological perturbation (e.g. drug, diet, disease) and determining the biological significance of these changes. The Metabolomics Research Group consists of members from academic core and research laboratories, industrial analytical laboratories and providers of metabolomic services, analytical standards and instrumentation.

Current Membership

Ryan Sheldon (Chair) - Van Andel Institute
Amrita K. Cheema - Georgetown University
Caroline Chidley - University of Massachusetts Chan Medical School
Daniel Cuthbertson - Agilent Technologies
Maryam Goudarzi - Sciex
Tytus Mak - NIST
Magnus Palmblad - Leiden University Medical Center
Reza Salek - International Agency for Research on Cancer
Chris W. Turck - Max Planck Institute of Psychiatry
Sue Weintraub (Executive Board Liaison) - University of Texas Health Science Center at San Antonio

Studies

Activities

Protocols

Membership History

Member Name Organization Details
Dr. Pavel AronovStanford University Member: 03/09 - 03/12
Dr. John M AsaraBeth Israel Deaconess Medical CenterMember: 03/10 - 03/15
Stephen BrownMember: - 3/15
Dr. Christopher ColangeloPrimary IonPrimary Ion
Dr. Nathan DodderNISTMember: 03/09 - 03/10
Dr. Brenda KeslerThermo Fisher ScientificMember: 03/09 - 02/11
Dr Thomas NeubertNew York Univ Sch of MedMember: 03/14 - 03/15 Liaison: 03/13 - 03/14
Dr Thomas M. O'ConnellUniversity of North CarolinaMember: 03/09 - 11/10
Dr. Andrew PattersonPenn State UniversityMember: 04/14 - 03/17
Dr. Brett S PhinneyProteomics Core UC Davis Genome Center EB Liaison: 02/11 - 03/12
Prof. Vladimir ShulaevUniversity of North Texas Member: 03/10 - 03/13
Jack SimpsonEB Liaison: 04/12 - 03/13
Dr. Vladimir V. TolstikovUC Davis Genome CenterMember: 03/09 - 05/12
Chris W TurckMax Planck Institute of Psychiatry Ad hoc: 02/11 - 05/12 EB Liaison: 03/10 - 02/11
Baljit Kaur UbhiSciexMember through 12/21
Dr. William R. WikoffUniversity of California, Davis Chair: 03/10 - 05/12 Member: 03/09 - 03/10 Member: 05/12 - 03/13

Publications

  1. The ABRF Metabolomics Research Group 2013 Study: Investigation of Spiked Compound Differences in a Human Plasma Matrix

    Amrita K. Cheema, John M. Asara, Yiwen Wang, Thomas A. Neubert, Vladimir Tolstikov, Chris W. Turck

  2. The ABRF Metabolomics Research Group 2016 Exploratory Study: Investigation of Data Analysis Methods for Untargeted Metabolomics

    Christoph W. Turck, Tytus D. Mak, Maryam Goudarzi, Reza M. Salek, Amrita K. Cheema

Questions or interest in joining an ABRF research group?